Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment.
Ottaiano A, Santorsola M, Ianniello M, Ceccarelli A, Casillo M, Sabbatino F, Petrillo N, Cascella M, Caraglia F, Picone C, Perri F, Sirica R, Zappavigna S, Nasti G, Savarese G, Caraglia M. Ottaiano A, et al. Among authors: perri f. J Transl Med. 2024 Apr 22;22(1):379. doi: 10.1186/s12967-024-05184-w. J Transl Med. 2024. PMID: 38650006 Free PMC article.
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions.
Ottaiano A, Circelli L, Santorsola M, Savarese G, Fontanella D, Gigantino V, Di Mauro A, Capuozzo M, Zappavigna S, Lombardi A, Perri F, Cascella M, Granata V, Capuozzo M, Nasti G, Caraglia M. Ottaiano A, et al. Among authors: perri f. Mol Oncol. 2022 Jan;16(2):319-332. doi: 10.1002/1878-0261.13122. Epub 2021 Nov 19. Mol Oncol. 2022. PMID: 34668636 Free PMC article.
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survival.
Ottaiano A, Santorsola M, Circelli L, Perri F, Cascella M, Sabbatino F, Capuozzo M, Granata V, Zappavigna S, Lombardi A, Scrima M, Petrillo N, Ianniello M, Casillo M, Gualillo O, Nasti G, Caraglia M, Savarese G. Ottaiano A, et al. Among authors: perri f. Front Med (Lausanne). 2023 Jan 23;10:1091634. doi: 10.3389/fmed.2023.1091634. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36756182 Free PMC article.
Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis.
Ottaiano A, Iacovino ML, Santorsola M, Facchini S, Iervolino D, Perri F, Nasti G, Quagliariello V, Maurea N, Ronchi A, Facchini BA, Bignucolo A, Berretta M. Ottaiano A, et al. Among authors: perri f. J Transl Med. 2024 Jan 30;22(1):119. doi: 10.1186/s12967-024-04889-2. J Transl Med. 2024. PMID: 38291479 Free PMC article. Review.
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Ottaiano A, Circelli L, Lombardi A, Scala S, Martucci N, Galon J, Buonanno M, Scognamiglio G, Botti G, Hermitte F, Savarese G, D'Amore L, Tatangelo F, Di Mauro A, Liguori G, Trotta AM, Napolitano M, Capozzi M, Tafuto S, Perri F, La Rocca A, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: perri f. Cell Death Dis. 2020 Apr 24;11(4):275. doi: 10.1038/s41419-020-2480-6. Cell Death Dis. 2020. PMID: 32332709 Free PMC article.
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Ottaiano A, Scala S, Santorsola M, Trotta AM, D'Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, Picone C, Petrillo A, Perri F, Tatangelo F, Di Mauro A, Albino V, Izzo F, Rega D, Pace U, Di Marzo M, Chiodini P, De Feo G, Del Prete P, Botti G, Delrio P, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: perri f. Ther Adv Med Oncol. 2021 Mar 24;13:1758835921989223. doi: 10.1177/1758835921989223. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33854566 Free PMC article.
KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer.
Ottaiano A, Nasti G, Santorsola M, Altieri V, Di Fruscio G, Circelli L, Luce A, Cossu AM, Scognamiglio G, Perri F, Correra M, Belli A, Delrio P, Botti G, Caraglia M. Ottaiano A, et al. Among authors: perri f. Front Oncol. 2021 Mar 29;11:632962. doi: 10.3389/fonc.2021.632962. eCollection 2021. Front Oncol. 2021. PMID: 33854968 Free PMC article.
330 results